LOGIN  |  REGISTER
Cue Biopharma

QHSLab (OTCMKTS: USAQ) Stock Quote

Last Trade: US$0.09
Volume: 31,455
5-Day Change: -2.15%
YTD Change: 1.11%
Market Cap: US$930K

Latest News From QHSLab

WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced the appointment of Dr. Marcos Sanchez-Gonzalez as the new Vice President of Medical and Scientific Affairs. Strategic Role and Objectives In his new role, Dr. Sanchez-Gonzalez... Read More
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended March 31, 2024. Financial Highlights: ● First Quarter Revenues were $488,587, a 38% increase over the $352,799... Read More
WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, today reported its financial and operational results for the fiscal year ended December 31, 2023. The year was marked by robust revenue growth, significant... Read More
This integration allows QHSLab access to more than 160,000 providers that are the exact match for target providers. WEST PALM BEACH, FL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce the seamless... Read More
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ● In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from the $269,323 reported in Q3 2022. ● Achieved a 55% gross margin over the nine months ending September 30, 2023, representing a 551-basis point growth in gross profit compared to the same period in 2022, and realized a remarkable... Read More
WEST PALM BEACH, FL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce that since the start of Q4 2023 it has gained six new multi-location customer accounts for its Integrated Service Program (ISP) in... Read More
WEST PALM BEACH, FL, Oct. 18, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce a series of accomplishments year-to-date (YTD) demonstrating the company's commitment to transforming patient care through technology... Read More
324% Sequential Revenue Growth in Q1 2023 Compared to Q4 2022 for its Digital Medicine Services. ● Total Q1 2023 revenue of $352,799 increased 32% over Q4 2022 revenue ● Expanded gross margin in Q1 2023 to 53% resulting in a 300-basis point increase in gross profit compared to the Q4 2022 ● Digital Medicine Subscription and Services Recurring Revenue combined grew by 168% in Q1 2023 compared to Q4 2022 ● Shareholders are... Read More
WEST PALM BEACH, FL, Feb. 16, 2023 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, announces entry into a representation agreement with Florida based, Healthcare Information Technology Specialists, LLC. QHSLab, Inc. (QHSLab) and Healthcare... Read More
QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors focused on the digital health community, many of which are currently witnessing poor outcomes from their previous investments. Multiple digital health companies have shed millions without creating a revenue stream. QHSLab is an alternative for investors to refocus and recoup on these... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB